AVITA Medical, Inc. (RCEL)
USD 11.56
(-7.67%)
USD 11.56
(-7.67%)
| Breakdown | 2022 | 2021 | 2020 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|
| Revenue | 50.56 Million | 14.26 Million | 20.66 Million | 1.25 Million | 1.18 Million | 1 Million |
| Cost of Revenue | 8.87 Million | 2.97 Million | 4.3 Million | 737.7 Thousand | 505.63 Thousand | 401.56 Thousand |
| Gross Profit | 41.68 Million | 11.29 Million | 16.35 Million | 517.47 Thousand | 674.99 Thousand | 600.43 Thousand |
| Operating Expenses | 80.77 Million | 53.96 Million | 77.2 Million | 19.14 Million | 13.34 Million | 11.95 Million |
| Selling, General and Administrative Expenses | 66.45 Million | 49.43 Million | 70.61 Million | 21.21 Million | 13.9 Million | 10.93 Million |
| Research and Development Expenses | 20.35 Million | 8.46 Million | 13.27 Million | 8.45 Million | 6.27 Million | 3.45 Million |
| Other Expenses | - | 686 Thousand | - | - | - | - |
| Cost and Expenses | 89.65 Million | 56.94 Million | 81.51 Million | 19.88 Million | 13.85 Million | 12.35 Million |
| Operating Income | -40.4 Million | -42.67 Million | -61.84 Million | -18.7 Million | -12.67 Million | -11.35 Million |
| Interest Expense | - | 33 Thousand | - | - | - | - |
| Income Tax Expense | 52.88 Thousand | 4000.00 | 5796.00 | 1.45 Million | 1.04 Million | 971.88 Thousand |
| Earnings before Tax | -39.11 Million | -42.02 Million | -60.89 Million | -18.65 Million | -12.55 Million | -11.24 Million |
| Net Income | -39.16 Million | -42.03 Million | -60.9 Million | -17.2 Million | -11.51 Million | -10.27 Million |
| Earnings Per Share Basic | -1.57 | -2.07 | -3.00 | -1.84 | -1.72 | -2.06 |
| Earnings Per Share Diluted | -1.57 | -2.07 | -3.00 | -1.85 | -1.72 | -2.06 |
| Weighted Average Shares Outstanding | 25 Million | 20.29 Million | 20.29 Million | 9.29 Million | 6.69 Million | 4.98 Million |
| Weighted Average Shares Outstanding (Diluted) | 25 Million | 20.29 Million | 20.29 Million | 9.32 Million | 6.69 Million | 4.98 Million |
| Gross Margin | 0.82 | 0.79 | 0.79 | 0.41 | 0.57 | 0.60 |
| EBIT Margin | -0.78 | -2.91 | -2.96 | -14.78 | -10.61 | -11.25 |
| Profit Margin | -0.77 | -2.95 | -2.95 | -13.71 | -9.75 | -10.25 |
| EBITDA | -39.56 Million | -41.52 Million | -61.16 Million | -18.55 Million | -12.53 Million | -11.27 Million |
| Earnings Before Tax Margin | -0.80 | -2.99 | -2.99 | -14.90 | -10.73 | -11.33 |
| Breakdown | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY | 2022 Q4 | 2022 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 21.22 Million | 17.64 Million | 10.55 Million | 50.56 Million | 9.45 Million | 14.21 Million |
| Cost of Revenue | 3.28 Million | 3.3 Million | 2.49 Million | 8.87 Million | 1.97 Million | 2.39 Million |
| Gross Profit | 17.93 Million | 14.33 Million | 13.28 Million | 41.68 Million | 11.9 Million | 11.82 Million |
| Operating Expenses | 31.45 Million | 29.89 Million | 27.02 Million | 80.77 Million | 19.72 Million | 20.54 Million |
| Selling, General and Administrative Expenses | 25.77 Million | 24.26 Million | 22.19 Million | - | 17.13 Million | 16.28 Million |
| Research and Development Expenses | 6.83 Million | 7.62 Million | 6.85 Million | - | 4.96 Million | 5.93 Million |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 34.74 Million | 33.2 Million | 29.52 Million | 89.65 Million | 21.7 Million | 22.93 Million |
| Operating Income | -14.34 Million | -16.75 Million | -14.82 Million | -40.4 Million | -8.67 Million | -8.98 Million |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | 17.11 Thousand | 19.51 Thousand | 44.87 Thousand | 52.88 Thousand | 35.25 Thousand | 6254.00 |
| Earnings before Tax | -13.53 Million | -15.57 Million | -13.74 Million | -39.11 Million | -7.82 Million | -8.73 Million |
| Net Income | -13.55 Million | -15.59 Million | -13.79 Million | -39.16 Million | -7.86 Million | -8.73 Million |
| Earnings Per Share Basic | -0.53 | -0.62 | -0.55 | - | -0.31 | -0.35 |
| Earnings Per Share Diluted | -0.53 | -0.62 | -0.55 | - | -0.31 | -0.35 |
| Weighted Average Shares Outstanding | 25.4 Million | 25.23 Million | 25.2 Million | 25 Million | 25.08 Million | 25 Million |
| Weighted Average Shares Outstanding (Diluted) | 25.4 Million | 25.23 Million | 25.2 Million | 25 Million | 25.08 Million | 25 Million |
| Gross Margin | 0.85 | 0.81 | 0.84 | 0.82 | 0.86 | 0.83 |
| EBIT Margin | -0.66 | -0.94 | -0.93 | - | -0.61 | -0.62 |
| Profit Margin | -0.64 | -0.88 | -0.87 | -0.77 | -0.57 | -0.61 |
| EBITDA | -14.09 Million | -16.53 Million | -14.62 Million | - | -8.48 Million | -8.77 Million |
| Earnings Before Tax Margin | -0.68 | -0.95 | -0.94 | -0.80 | -0.62 | -0.63 |
BIOV
CDIIQ
PLNT
1196
CARV
CHD